Recognition for Australian research in glioblastoma imaging

As reported in a previous post, ACQI-affiliated PhD student Nathaniel Barry published a quantitative analysis of the benchmarking performed for the TROG 18.06 FIG trial in the European Journal of Nuclear Medicine and Molecular Imaging. Nathaniel’s paper was highlighted in an editorial published in the journal, identifying the study and the associated clinical trial as establishing a “blueprint” for obtaining evidence pertaining to the utility of molecular imaging. TROG Cancer Research has set a high bar for prospective clinical trials and ensuring the quality of the data collected. We are working with TROG and the trial investigators to ensure the outcomes from the trial can be translated for subsequent clinical benefit, and Nathaniel’s work will be pivotal in that process.